Market Access News | pharmaphorum

News

Gilead has FDA approval for a twice-yearly PrEP drug, but could proposed cuts to US funding for HIV prevention programmes hinder its take-up?

News

People in England and Wales with severe skin disease GPP will soon be able to access a new therapy currently denied to patients in Scotland.

News

RFK Jr's interference in the ACIP is putting patients at risk, claim the 17 members of the panel abruptly fired last week.

News

Major changes to medical device regulations in the UK have come into force with an overhaul of post-market surveillance requirements.

News

FDA Commissioner Marty Makary has revealed a new priority review voucher programme for new medicines deemed to be of national priority for the US.

News

CSL has won FDA approval for Andembry, its once-monthly subcutaneous drug to prevent hereditary angioedema (HAE) attacks.